Loading Events

Event

May 2021 25
Time: 8:00 AM

Tuesday, May 18 from 7AM-10:30AM EST | Friday, May 21 from 8AM-11:30AM EST | Tuesday, May 25 from 8AM-11:30AM EST

The global response to COVID-19 has pushed the boundaries on what is possible for rapid pandemic response in several areas, including advancing vaccine research and development, bolstering vaccine distribution and supply chains, reinforcing non-vaccine public health interventions and countermeasures, and encouraging global coordination, partnerships and financing. Furthermore, the global COVID-19 response has provided new data around the efficacy and best practices surrounding pandemic planning and response.

This global public workshop will convene international experts, thought-leaders, and other stakeholders to discuss the emerging evidence on these unprecedented actions related to COVID-19 that could inform and advance pandemic and seasonal influenza vaccine preparedness efforts and subsequent response.


Agenda:

Panel 1: Creating Conditions for Innovation in Research and Development

  • Beverly Taylor, Moderator | Head, Influenza Scientific Affairs, Seqirus Vaccines; Chair, Influenza Vaccine Supply Task Force, IFPMA
  • Charu Kaushic | Chair, Global Research Collaboration for Infectious Disease Preparedness; Scientific Director, Canadian Institutes of Health Research
  • Maria Elena Bottazzi | Associate Dean, National School of Tropical Medicine, Baylor College of Medicine
  • Carolyn Finkle | Chief Operating Officer, Medicago


Panel 2: Communicating the Science of Viruses and Vaccines

  • Heidi Larson, Moderator | Founding Director, Vaccine Confidence Project, London School of Hygiene and Tropical Medicine
  • Benjamin Cowling | Head, Division of Epidemiology and Biostatistics, Hong Kong University
  • Priya Bahri | Principal Scientific Officer, European Medicines Agency
  • Sherine Guirguis | Director, Common Thread
  • Sarah Zhang | Staff Writer, The Atlantic

 

Breakout sessions

Breakout 1: Information Sharing and Communications

  • Heidi Larson, Moderator | Founding Director, Vaccine Confidence Project, London School of Hygiene and Tropical Medicine
  • Denise Gray-Felder | President and CEO, CFSC Consortium
  • Priya Bahri | Principal Scientific Officer, European Medicines Agency
  • Glen Nowak | Director of Center for Health & Risk Communication, University of Georgia
  • Sergio Cecchini | Coordinator, Africa Infodemic Response Alliance

Breakout 2: Financing and Investment

  • Phyllis Arthur, Moderator | Vice President, Infectious Diseases & Diagnostics Policy at Biotechnology Innovation Organization
  • Ran Balicer | Chief Innovation Officer, Clalit Health Services
  • Maria Elena Bottazzi | Associate Dean, National School of Tropical Medicine, Baylor College of Medicine

Breakout 3: Equity in Research and Communication

  • Patricia Garcia, Moderator | Professor, Universidad Peruana Cayetano Heredia
  • Sherine Guirguis | Director, Common Thread
  • Tolbert Nyenswah | Senior Research Associate, Johns Hopkins University

The workshop will feature invited presentations and discussions to:

  • Highlight late-breaking developments in vaccine R&D or manufacturing that can inform future pandemic influenza planning.
  • Explore current global coordination frameworks and opportunities for future pandemic planning, including funding mobilization, technology transfer, and surveillance and data sharing.
  • Discuss lessons learned from COVID-19 vaccine rollout and delivery, as well as public health countermeasures sourcing, including inventory unpredictability and cascading effects of shortages of critical inputs and ancillary materials.
  • Explore gaps in One Health governance, global surveillance, and risk assessment.
  • Highlight equity challenges in the “last mile” of medical product delivery, and needs identified in order to improve future planning and deployment of products.
  • Explore innovations in surveillance and data sharing during COVID-19 and other epidemics that can be adapted and scaled for future influenza events.
  • Discuss best practices for communicating emerging research and building public confidence in vaccines and public health measures.

Join Our Community

Sign up for NAM email updates